Deterioration of Acute Stroke

  • K. Asplund

Abstract

There is no agreement on the terminology or definitions to characterize a stroke patient who deteriorates soon after the onset of symptoms. The terms progressing (or progressive) stroke, stroke-in-progression, evolving stroke, stroke-in-evolution, and deteriorating stroke have all been used. Deteriorating stroke is often used to encompass not only cerebral but also systemic causes of deterioration [13]. It is attractive to use this term because it describes the phenomenon without giving commitments as to the cause, and it challenges us to seek for underlying mechanisms, including systemic ones, without predetermined minds. “Deteriorating stroke” is therefore used in the present article.

Keywords

Permeability Ischemia Propa Aspirin Heparin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Baker RN, Broward JA, Fang HC, et al (1962) Anticoagulant therapy in cerebral infarction. Report on a cooperative study. Neurology 12:828–835Google Scholar
  2. 2.
    Black KL (1984) Leucotriene C4 induces vasogenic cerebral edema in rats. Prostaglandin Leukot Med 14:339–340CrossRefGoogle Scholar
  3. 3.
    Britton M, Rödén (1985) Progression of stroke after arrival at hospital. Stroke 16:629–632PubMedCrossRefGoogle Scholar
  4. 4.
    Carter AB (1961) Anticoagulant treatment in progressing stroke. Br Med J 2:70–73PubMedCrossRefGoogle Scholar
  5. 5.
    Cerebral Embolism Task Force (1989) Cardiogenic embolism. The second report of the Cerebral Embolism Task Force. Arch Neurol 46:727–743CrossRefGoogle Scholar
  6. 6.
    Chen ST, Chen SD, Hsu CY, Hogan EL (1989) Progression of hypertensive intracerebral hemorrhage. Neurology 39:1509–1514PubMedGoogle Scholar
  7. 7.
    Dávalos A, Cendra E, Teruel J, Martinez M, Genís D (1990) Deteriorating ischemic stroke. Risk factors and prognosis. Neurology 40:1865–1869PubMedGoogle Scholar
  8. 8.
    Duke RJ, Block RF, Turpie AG, Trebilcock R, Bayer N (1986) Intravenous heparin for the prevention of stroke progression in acute partial stable stroke: A randomized controlled trial. Arch Intern Med 105:825–828Google Scholar
  9. 9.
    Eriksson S, Asplund K, Hägg E, Lithner F, Strand T, Wester PO (1987) Clinical profiles of cerebrovascular disorders in a population-based patient sample. J Chron Dis 40:1025–1032PubMedCrossRefGoogle Scholar
  10. 10.
    Feuerstein G (1989) Eicosanoids in deteriorating stroke. Ann NY Acad Sci 559:313–322PubMedCrossRefGoogle Scholar
  11. 11.
    Fisher CM (1961) Anticoagulant therapy in cerebral thrombosis and cerebral embolism: A national cooperative study, interim report. Neurology 11:119–131PubMedCrossRefGoogle Scholar
  12. 12.
    Gautier JC (1985) Stroke-in-progression. Stroke 16:729–733PubMedCrossRefGoogle Scholar
  13. 13.
    Hachinski V, Norris J (1985) The deteriorating stroke. In: The acute stroke. FA Davis, Philadelphia, p 123Google Scholar
  14. 14.
    Haley EC, Jr., Kassell NF, Torner JC (1988) Failure of heparin to prevent progression in progressing ischemic infarction. Stroke 19: 10–14PubMedCrossRefGoogle Scholar
  15. 15.
    Heye N, Campos A, Kannuki S, Cervós-Navarro J (1991) Effects of triflusal and acetylsalicylic acid on microthrombi formation in experimental brain ischemia. Exp Pathol 41:31–36PubMedCrossRefGoogle Scholar
  16. 16.
    Heye N, Paetzold C, Cervós-Navarro J (1991) The role of microthrombi and microcirculatory factors in localization and evolution of focal cerebral ischemia. Neurosurg Rev 14:7–16PubMedGoogle Scholar
  17. 17.
    Ho C-H, Hu H-H, Wong W-J (1989) The serial hemostasis-related changes in patients with cerebral infarction: Comparison between progressing and non-progressing stroke. Thromb Res 56:635–647PubMedCrossRefGoogle Scholar
  18. 18.
    ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 13 August:349–360Google Scholar
  19. 19.
    Jones HR, Jr., Millikan CH (1976) Temporal profile (clinical course) of acute carotid system cerebral infarction. Stroke 7:64–71PubMedCrossRefGoogle Scholar
  20. 20.
    Jones HR, Jr., Millikan CH, Sandok BA (1980) Temporal profile (clinical course) of acute vertebrobasilar system cerebral infarction. Stroke 11:173–177PubMedCrossRefGoogle Scholar
  21. 21.
    Jörgensen L, Torvik A (1969) Ischaemic cerebrovascular diseases in an autopsy series. Part 2. Prevalence, location, pathogenesis, and clinical course of cerebral infarcts. J Neurol Sci 9:285–320PubMedCrossRefGoogle Scholar
  22. 22.
    Lust WD, Assaf HM, Ricci AJ, Ratcheson RA, Sterau LL (1988) A role for gamma-aminobutyric acid (GABA) in the evolution of delayed neuronal death following ischemia. Metab Brain Dis 3:287–292PubMedCrossRefGoogle Scholar
  23. 23.
    Marsh EE, Adams HP, Biller J, et al (1989) Use of antithrombotic drugs in the treatment of acute ischemic stroke: A survey of neurologists in practice in the United States. Neurology 39:1631–1634PubMedGoogle Scholar
  24. 24.
    Mohammed AA, Gotoh O, Graham DI, et al (1985) Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion. Ann Neurol 18:705–711CrossRefGoogle Scholar
  25. 25.
    Nehls DG, Mendelow AD, Graham DI, Sinar EJ, Teasdale GM (1988) Experimental intracerebral hemorrhage: Progression of hemodynamic changes after production of a spontaneous mass lesion. Neurosurgery 23:439–444PubMedCrossRefGoogle Scholar
  26. 26.
    Norrving B, Cronqvist S (1989) Clinical and radiologic features of lacunar versus nonlacunar minor stroke. Stroke 20:59–64PubMedCrossRefGoogle Scholar
  27. 27.
    Okada Y, Yamagushi T, Minematsu K, et al (1989) Hemorrhagic transformation in cerebral embolism. Stroke 20:598–603PubMedCrossRefGoogle Scholar
  28. 28.
    Petito CK, Pulsinelli WA (1984) Sequential development of reversible and irreversible neuronal damage following cerebral ischemia. J Neuropathol Exp Neurol 43:141–153PubMedCrossRefGoogle Scholar
  29. 29.
    Price TR (1986) Progressing ischemic stroke. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM (eds) Stroke: Pathophysiology, diagnosis, and management. Churchill Livingstone, New York, p 1059Google Scholar
  30. 30.
    Slivka A, Levy D (1990) Natural history of progressive ischemic stroke in a population treated with heparin. Stroke 21:1657–1662PubMedCrossRefGoogle Scholar
  31. 31.
    Stegmayr B, Asplund K (1993) Stroke in the population: Quality of routine data vs. a population-based registry. Neuroepidemiology (In Press)Google Scholar
  32. 32.
    Strand T, Asplund K, Eriksson S, Hägg E, Lithner F, Wester PO (1985) A non-intensive stroke unit reduces functional disability and the need for long-term hospitalization. Stroke 16:29–34PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • K. Asplund
    • 1
  1. 1.Department of MedicineUniversity HospitalUmeåSweden

Personalised recommendations